SOX2 is a stem cell transcription factor that controls self-renewal and pluripotency in cancer stem cells, and upregulation of SOX2 could be used as a marker for evaluating prognosis and treatment effectiveness for HCC (Hosseini-khah et al. 2021). Here, SOX2 is linked to cancer.